Literature DB >> 15924890

Microbiology of chronic leg and pressure ulcers: clinical significance and implications for treatment.

John R Ebright1.   

Abstract

Chronic pressure ulcers and leg ulcers are common, especially in the elderly, and are a source of much distress and disability. Health care providers must distinguish between clinically unimportant but predictable colonization of these wounds and clinically relevant infection.Infection may present as increased local pain, cellulitis, local abscess,necrotizing fasciitis, osteomyelitis, bacteremia, or sepsis. For most of these conditions, systemic antibiotics are necessary. The use of topical antimicrobial agents as a means of promoting healing in clinically uninfected wounds is a subject of active investigation at this time. Currently, evidence is insufficient to support routine use of anti-microbial agents for this purpose. A quantitative tissue culture taken from the ulcer bed, revealing greater than 10(5) organisms/g of tissue appears to increase the risk of failure of ulcer wound closure by graft or flap. A short course of topical or systemic antibiotics before surgery in these instances is advisable.

Entities:  

Mesh:

Year:  2005        PMID: 15924890     DOI: 10.1016/j.cnur.2004.09.003

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  8 in total

1.  Photobiomodulation by dual-wavelength low-power laser effects on infected pressure ulcers.

Authors:  Andrezza Maria Côrtes Thomé Lima; Luiz Philippe da Silva Sergio; Larissa Alexsandra da Silva Neto Trajano; Bianca Paschoal de Souza; João Pedro da Motta Mendes; Adriano Fonseca Ribeiro Cardoso; Caroline Pisa Figueira; Beatriz Dos Anjos Tavares; Daniella Sousa Figueira; André Luiz Mencalha; Eduardo Tavares Lima Trajano; Adenilson de Souza da Fonseca
Journal:  Lasers Med Sci       Date:  2019-08-31       Impact factor: 3.161

2.  Enterococcus faecalis Antagonizes Pseudomonas aeruginosa Growth in Mixed-Species Interactions.

Authors:  Casandra Ai Zhu Tan; Ling Ning Lam; Goran Biukovic; Eliza Ye-Chen Soh; Xiao Wei Toh; José A Lemos; Kimberly A Kline
Journal:  J Bacteriol       Date:  2022-06-27       Impact factor: 3.476

3.  Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles.

Authors:  Evan M Hetrick; Jae Ho Shin; Heather S Paul; Mark H Schoenfisch
Journal:  Biomaterials       Date:  2009-02-23       Impact factor: 12.479

4.  Evaluation of the bacterial diversity of pressure ulcers using bTEFAP pyrosequencing.

Authors:  Drake M Smith; David E Snow; Eric Rees; Ann M Zischkau; J Delton Hanson; Randall D Wolcott; Yan Sun; Jennifer White; Shashi Kumar; Scot E Dowd
Journal:  BMC Med Genomics       Date:  2010-09-21       Impact factor: 3.063

5.  Clinical efficacy of a silver-releasing foam dressing in venous leg ulcer healing: a randomised controlled trial.

Authors:  Patricia Senet; Renzo Bause; Bo Jørgensen; Karsten Fogh
Journal:  Int Wound J       Date:  2013-02-04       Impact factor: 3.315

6.  Reduction of a multidrug-resistant pathogen and associated virulence factors in a burn wound infection model: further understanding of the effectiveness of a hydroconductive dressing.

Authors:  Bonnie C Carney; Rachel T Ortiz; Rachael M Bullock; Nicholas J Prindeze; Lauren T Moffatt; Martin C Robson; Jeffrey W Shupp
Journal:  Eplasty       Date:  2014-12-10

7.  Evaluation of physiological risk factors, oxidant-antioxidant imbalance, proteolytic and genetic variations of matrix metalloproteinase-9 in patients with pressure ulcer.

Authors:  Khlifi Latifa; Sahli Sondess; Graiet Hajer; Ben-Hadj-Mohamed Manel; Khelil Souhir; Bouzidi Nadia; Jaballah Abir; Ferchichi Salima; Miled Abdelhedi
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

8.  Interactions of methicillin resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in polymicrobial wound infection.

Authors:  Irena Pastar; Aron G Nusbaum; Joel Gil; Shailee B Patel; Juan Chen; Jose Valdes; Olivera Stojadinovic; Lisa R Plano; Marjana Tomic-Canic; Stephen C Davis
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.